Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization

Journal of Gastroenterology and Hepatology
Nam Hee KimHong Joo Kim

Abstract

The aim of this study is to determine the impact of clinically evident portal hypertension (CEPH) on prognosis of hepatocellular carcinoma (HCC) patients with Child-Pugh A cirrhosis who underwent transarterial chemoembolization (TACE). A retrospective data analysis was performed for a total of 388 treatment-naïve HCC patients with Child-Pugh A cirrhosis who underwent TACE as first-line treatment from January 2000 to June 2014. Cumulative occurrence rate of complete response (CR), progression-free survival (PFS), and overall survival (OS) were compared between patients with CEPH and those without CEPH (esophageal/gastric varices or low platelet count [< 100 000 per mm3 ] associated with splenomegaly). Among 388 patients, 252 (64.9%) had CEPH, while 136 (35.1%) had no evidence of CEPH at the time of HCC diagnosis. Cumulative probability of the occurrence of CR was significantly lower in patients with CEPH than that in patients without CEPH (P < 0.001). Median PFS was significantly shorter in patients with CEPH than that in patients without CEPH (5 vs 31 months, P < 0.001). Five-year OS rate was significantly lower in patients with CEPH than that in patients without CEPH (41.5% vs 77.5%, P < 0.001). Multivariate analysis indicated...Continue Reading

References

Apr 1, 1999·The British Journal of Surgery·F PayeJ Belghiti
Oct 28, 2004·Gastroenterology·Giovanna FattovichFrancesco Donato
Oct 25, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Edoardo Giovanni GianniniUNKNOWN Italian Liver Cancer (ITA.LI.CA.) Group
Nov 18, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Puneeta Tandon, Guadalupe Garcia-Tsao
Jun 16, 2007·Gastroenterology·Hashem B El-Serag, K Lenhard Rudolph
Feb 29, 2008·Journal of Hepatology·Josep M Llovet, Jordi Bruix
May 13, 2008·Gastroenterology·Arun J SanyalVincente Arroyo
Mar 24, 2009·Journal of Hepatology·Cristina RipollUNKNOWN Portal Hypertension Collaborative Group
Sep 3, 2009·Nature Reviews. Gastroenterology & Hepatology·Jaime BoschJuan Carlos García-Pagan
Feb 23, 2010·Seminars in Liver Disease·Riccardo Lencioni, Josep M Llovet
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
Oct 20, 2011·Cardiovascular and Interventional Radiology·Riccardo LencioniJean-Francois H Geschwind
Dec 16, 2011·World Journal of Gastroenterology : WJG·Andrea RuzzenenteAlfredo Guglielmi
Mar 2, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David Y Zhang, Scott L Friedman
Mar 20, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver, UNKNOWN European Organisation For Research And Treatment Of Cancer
Aug 1, 2012·Seminars in Oncology·Riccardo Lencioni
Aug 6, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mercedes Fernandez
Sep 13, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Annalisa BerzigottiJordi Bruix
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Apr 29, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·François FaitotEric Vibert
Mar 15, 2016·World Journal of Gastroenterology : WJG·Christina HacklSven A Lang

❮ Previous
Next ❯

Citations

Jan 8, 2019·European Journal of Gastroenterology & Hepatology·Jingxian GuChang Liu
Jul 19, 2019·United European Gastroenterology Journal·Bernhard ScheinerMatthias Pinter
Sep 27, 2018·Journal of Experimental & Clinical Cancer Research : CR·Hongliang LiuWei Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.